Showing results (131-140 of 165) with videos related to
Sort By:
Pageof 17
Journal of Robotic Surgery|September 18, 2016
Robotic hysterectomy and lymphadenectomy for endometrial cancer: technical aspects and details of success-the Ohio State University methodLeigh G Seamon, David E Cohn, Sue Valmadre, et al.British Journal of Clinical Pharmacology|November 9, 2024
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBYMita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, et al.Obstetrics and Gynecology|November 2, 2006
Improved survival with an intact DNA mismatch repair system in endometrial cancerDavid E Cohn, Wendy L Frankel, Kimberly E Resnick, et al.Cancer|November 20, 2016
What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data studyBunja J Rungruang, Austin Miller, Thomas C Krivak, et al.International Journal of Radiation Oncology, Biology, Physics|July 28, 2009
Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancerNina A Mayr, Jian Z Wang, Simon S Lo, et al.Gynecologic Oncology|June 10, 2014
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancerEric L Eisenhauer, Vanna Zanagnolo, David E Cohn, et al.Gynecologic Oncology|September 23, 2017
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyKathleen N Moore, David Tritchler, Kenneth M Kaufman, et al.Gynecologic Oncology|June 29, 2017
The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysisTaylor B Turner, Sarah E Dilley, Haller J Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2023
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyRobert F Ozols, Brian N Bundy, Benjamin E Greer, et al.Gynecologic Oncology|March 9, 2025
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)Jeanne Carter, Helen Q Huang, Bradley J Monk, et al.Pageof 17